Literature DB >> 22494452

Mortality and hospitalisation costs of rheumatic fever and rheumatic heart disease in New Zealand.

Richard J Milne1, Diana Lennon, Joanna M Stewart, Stephen Vander Hoorn, Paul A Scuffham.   

Abstract

AIMS: To estimate the annual mortality and the cost of hospital admissions for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) for New Zealand residents.
METHODS: Hospital admissions in 2000-2009 with a principal diagnosis of ARF or RHD (ICD9_AM 390-398; ICD10-AM I00-I099) and deaths in 2000-2007 with RHD as the underlying cause were obtained from routine statistics. The cost of each admission was estimated by multiplying its diagnosis-related group (DRG) cost weight by the national price for financial year 2009/2010.
RESULTS: There were on average 159 RHD deaths each year with a mean annual mortality rate of 4.4 per 100, 000 (95% confidence limit 4.2, 4.7). Age-adjusted mortality was five- to 10-fold higher for Māori and Pacific peoples than for non-Māori/Pacific. The mean age at RHD death (male/female) was 56.4/58.4 for Māori, 50.9/59.8 for Pacific and 78.2/80.6 for non-Māori, non-Pacific men and women. The average annual DRG-based cost of hospital admissions in 2000-2009 for ARF and RHD across all age groups was $12.0 million (95% confidence limit $11.1 million, $12.8 million). Heart valve surgery accounted for 28% of admissions and 71% of the cost. For children 5-14 years of age, valve surgery accounted for 7% of admissions and 27% of the cost. Two-thirds of the cost occurs after the age of 30.
CONCLUSIONS: ARF and RHD comprise a burden of mortality and hospital cost concentrated largely in middle age. Māori and Pacific RHD mortality rates are substantially higher than those of non-Māori/Pacific.
© 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2012        PMID: 22494452     DOI: 10.1111/j.1440-1754.2012.02446.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  11 in total

Review 1.  Screening for rheumatic heart disease: current approaches and controversies.

Authors:  Kathryn Roberts; Samantha Colquhoun; Andrew Steer; Bo Reményi; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-11-13       Impact factor: 32.419

2.  Rheumatic Heart Disease Patients' Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study.

Authors:  Alinur Adem; Tadesse Dukessa Gemechu; Habtemu Jarso; Wondu Reta
Journal:  Patient Prefer Adherence       Date:  2020-12-04       Impact factor: 2.711

3.  Estimating the likely true changes in rheumatic fever incidence using two data sources.

Authors:  J Oliver; N Pierse; D A Williamson; M G Baker
Journal:  Epidemiol Infect       Date:  2017-12-06       Impact factor: 4.434

4.  Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study.

Authors:  Tom Parks; Joseph Kado; Anne E Miller; Brenton Ward; Rachel Heenan; Samantha M Colquhoun; Till W Bärnighausen; Mariana Mirabel; David E Bloom; Robin L Bailey; Isimeli N Tukana; Andrew C Steer
Journal:  PLoS Negl Trop Dis       Date:  2015-09-15

Review 5.  Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.

Authors:  Michael G Baker; Jason Gurney; Jane Oliver; Nicole J Moreland; Deborah A Williamson; Nevil Pierse; Nigel Wilson; Tony R Merriman; Teuila Percival; Colleen Murray; Catherine Jackson; Richard Edwards; Lyndie Foster Page; Florina Chan Mow; Angela Chong; Barry Gribben; Diana Lennon
Journal:  Int J Environ Res Public Health       Date:  2019-11-15       Impact factor: 3.390

6.  Rising Ethnic Inequalities in Acute Rheumatic Fever and Rheumatic Heart Disease, New Zealand, 2000-2018.

Authors:  Julie Bennett; Jane Zhang; William Leung; Susan Jack; Jane Oliver; Rachel Webb; Nigel Wilson; Dianne Sika-Paotonu; Matire Harwood; Michael G Baker
Journal:  Emerg Infect Dis       Date:  2021-01       Impact factor: 6.883

7.  Estimating rheumatic fever incidence in New Zealand using multiple data sources.

Authors:  J Oliver; N Pierse; M G Baker
Journal:  Epidemiol Infect       Date:  2014-03-06       Impact factor: 4.434

8.  Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians.

Authors:  Samantha M Colquhoun; John R Condon; Andrew C Steer; Shu Q Li; Steven Guthridge; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2015-07-28       Impact factor: 5.501

9.  School-based Streptococcal A Sore-throat Treatment Programs and Acute Rheumatic Fever Amongst Indigenous Māori: A Retrospective Cohort Study.

Authors:  Liam Walsh; Sandra Innes-Smith; Janine Wright; Thanjon Michniewicz; Megan Tozer; Jonathan Humby; Richard Ngata; Diana Lennon; Joseph Scott-Jones; John Malcolm
Journal:  Pediatr Infect Dis J       Date:  2020-11       Impact factor: 3.806

Review 10.  Global epidemiology of valvular heart disease.

Authors:  Sean Coffey; Ross Roberts-Thomson; Alex Brown; Jonathan Carapetis; Mao Chen; Maurice Enriquez-Sarano; Liesl Zühlke; Bernard D Prendergast
Journal:  Nat Rev Cardiol       Date:  2021-06-25       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.